Abstract

Backgrounds: Biliary atresia (BA) is a very rare neonatal disease, however, it has been the most common cause of obstructive jaundice in infancy. The complex pathogenesis of BA is not entirely clear and a lot of possible pathogenic mechanisms have been proposed to explain the etiology of BA, including genetic, inflammatory, environmental and developmental abnormalities. As a transcription factor, USF2 gene rs916145 polymorphism has been shown to be related to the risk of BA.Methods: We examined the USF2 rs916145 genotype in a large case–control study consisting of 506 BA patients and 1473 healthy controls, using the MassARRAY iPLEX Gold system (Sequenom). Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the association between the USF2 gene rs916145 polymorphism and BA susceptibility.Results: The frequency of different genotypes showed no statistical significance (GG/GC, OR: 1.09, P=0.470, 95% CI: 0.87–1.35; GG/CC, OR: 0.86, P=0.378, 95% CI: 0.62–1.20). No obvious association was revealed between the USF2 gene rs916145 polymorphism and BA susceptibility.Conclusion: USF2 rs916145 polymorphism may not be the best predictor of BA.

Highlights

  • Biliary atresia (BA) is a very rare neonatal disease, this is the most common cause of obstructive jaundice in infants

  • The single nucleotide polymorphism (SNP) rs916145 of USF2 gene was examined in 506 cases and 1473 controls, which was consistent with HWE (HWE = 0.965) in the healthy controls

  • Genome-wide association studies (GWAS) that investigate the association of SNPs with diseases are usually taken to inquire the genetic underpinning of BA

Read more

Summary

Introduction

Biliary atresia (BA) is a very rare neonatal disease, this is the most common cause of obstructive jaundice in infants. BA manifests itself as the obliteration of the extrahepatic bile ducts, disrupting bile flow [2]. The incidence of BA shows various results in different racial groups, which is more common in Asian populations than that in West Europe (approximately 1/5000 Asians vs 1/18000 whites) [3]. The first choice for improving the short-term outcome in BA children is hepatoportoenterostomy (HPE) after surgical removal of duct remnants, most of them will progress to end-stage cirrhosis, eventually requiring liver transplant by adulthood [4,5]. Changing the poor perception of BA pathogenesis is a huge challenge as well as a hope for improvements of BA prognosis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call